- Home
- CLNN vs ICCM Comparison
CLNN vs ICCM Comparison
Compare CLNN & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNN | ICCM |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 43.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CLNN | ICCM |
|---|---|---|
| Price | $5.10 | $0.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $32.67 | $2.50 |
| AVG Volume (30 Days) | 68.0K | ★ 175.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | $82.05 | $31.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.28 | $0.54 |
| 52 Week High | $13.50 | $1.53 |
Technical Indicators
Market Signals| Indicator | CLNN | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 55.71 | 42.42 |
| Support Level | $3.43 | $0.54 |
| Resistance Level | $5.71 | $0.74 |
| Average True Range (ATR) | 0.45 | 0.03 |
| MACD | 0.18 | 0.00 |
| Stochastic Oscillator | 78.52 | 26.94 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.